Diploma PLC (LON:DPLM) Insider Ian El-Mokadem Buys 500 Shares

Diploma PLC (LON:DPLM) insider Ian El-Mokadem acquired 500 shares of the business’s stock in a transaction dated Monday, March 24th. The stock was purchased at an average price of GBX 3,948 ($51.11) per share, for a total transaction of £19,740 ($25,556.71).

Diploma Stock Down 0.3 %

Shares of Diploma stock opened at GBX 3,970 ($51.40) on Wednesday. Diploma PLC has a twelve month low of GBX 3,372 ($43.66) and a twelve month high of GBX 4,808 ($62.25). The stock has a market cap of £5.30 billion, a price-to-earnings ratio of 45.63, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The company has a fifty day moving average price of GBX 4,385.96 and a 200 day moving average price of GBX 4,379.51.

Diploma Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were paid a dividend of GBX 42 ($0.54) per share. This represents a dividend yield of 0.93%. The ex-dividend date of this dividend was Thursday, January 16th. This is a boost from Diploma’s previous dividend of $17.30. Diploma’s payout ratio is currently 65.52%.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. increased their target price on shares of Diploma from GBX 4,370 ($56.58) to GBX 4,420 ($57.22) and gave the stock a “neutral” rating in a research report on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Diploma has a consensus rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($59.13).

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.